Literature DB >> 26076222

Should we establish standards of care for management of elderly patients with inflammatory bowel disease?

Subrata Ghosh, Marietta Iacucci.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26076222      PMCID： PMC4467482          DOI： 10.1155/2015/862458

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN： 2291-2789


× No keyword cloud information.
  5 in total

1.  Characterization of inflammatory bowel disease in elderly hospitalized patients in a large central Canadian Health region.

Authors:  Peter Stepaniuk; Charles N Bernstein; Zoann Nugent; Harminder Singh
Journal:  Can J Gastroenterol Hepatol       Date:  2015-04-15

Review 2.  Novel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease.

Authors:  Marietta Iacucci; T Uraoka; M Fort Gasia; N Yahagi
Journal:  Can J Gastroenterol Hepatol       Date:  2014 Jul-Aug

3.  Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease.

Authors:  Amit Desai; Zachary A Zator; Punyanganie de Silva; Deanna D Nguyen; Joshua Korzenik; Vijay Yajnik; Ashwin N Ananthakrishnan
Journal:  Inflamm Bowel Dis       Date:  2013-02       Impact factor: 5.325

4.  Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity.

Authors:  Manie Juneja; Leonard Baidoo; Marc B Schwartz; Arthur Barrie; Miguel Regueiro; Michael Dunn; David G Binion
Journal:  Dig Dis Sci       Date:  2012-02-23       Impact factor: 3.199

5.  Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Authors:  Laurent Beaugerie; Nicole Brousse; Anne Marie Bouvier; Jean Frédéric Colombel; Marc Lémann; Jacques Cosnes; Xavier Hébuterne; Antoine Cortot; Yoram Bouhnik; Jean Pierre Gendre; Tabassome Simon; Marc Maynadié; Olivier Hermine; Jean Faivre; Fabrice Carrat
Journal:  Lancet       Date:  2009-11-07       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.